Compare LFVN & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LFVN | DTF |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.0M | 80.5M |
| IPO Year | 1996 | 1995 |
| Metric | LFVN | DTF |
|---|---|---|
| Price | $6.43 | $11.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $11.00 | N/A |
| AVG Volume (30 Days) | ★ 61.7K | 4.8K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | ★ 226.09 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $203,204,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.63 | ★ N/A |
| Revenue Growth | ★ 1.86 | N/A |
| 52 Week Low | $3.90 | $11.21 |
| 52 Week High | $14.28 | $11.61 |
| Indicator | LFVN | DTF |
|---|---|---|
| Relative Strength Index (RSI) | 48.54 | 51.19 |
| Support Level | $6.05 | $11.40 |
| Resistance Level | $6.51 | $11.59 |
| Average True Range (ATR) | 0.28 | 0.06 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 37.18 | 62.50 |
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing mainly in a diversified portfolio of investment-grade tax-exempt obligations.